New York Presbyterian Hospital (Cornell Campus) Program

The Hematology/Medical Oncology Fellowship Program at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is a comprehensive three-year accredited program designed to provide fellows with dual board eligibility in hematology and medical oncology.

Upon completion of this program, fellows will have acquired the necessary skills and knowledge to excel in both clinical practice and research, supported by a distinguished faculty comprising around 100 full-time members involved in mentorship roles.

Clinical Training

Clinical training is conducted at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center, which is an 850-bed academic facility situated on Manhattan's Upper East Side. This institution serves a large, diverse patient demographics as a community hospital, along with functioning as a tertiary care referral center.

The first year of fellowship training is predominantly dedicated to clinical practice, combining inpatient and outpatient care. During this year, fellows partake in monthly rotations through five clinical services, which include:

• Benign Hematology Consult Service
• Solid Tumor Consult Service
• Bone Marrow Transplant (Allo Service)
• Bone Marrow Transplant (Auto Service/CAR-T)/Myeloma
• Leukemia and Lymphoma

Research Training

The second year emphasizes research, spanning 18 months. Fellows have the opportunity to focus on three main research tracks: Basic, Translational, or Clinical. Each fellow is encouraged to identify interests and work on projects under the guidance of seasoned physician-scientists and clinical research faculty. The program stresses the importance of research design, methodology, and data interpretation.

Areas of active research conducted by faculty include:

• Angiogenesis
• Hematopoiesis
• Stem Cell Biology
• Immunology
• Vascular Biology
• Viral Oncogenesis
• Tumor Biology
• Cellular Adhesion Mechanisms
• Gene Regulation
• Molecular Pathogenesis
• AIDS Virology
• Cell Signaling

Clinical research access is facilitated through affiliation with a large multi-institutional cooperative group (Cancer and Leukemia Group B) and various institutional programs related to leukemia, bone marrow/stem cell transplant, gene therapy, and immunotherapy.

Fellows may also commence a two-year master's degree in Clinical Investigation during their second year and can choose to engage in other formalized research training programs.

Third Year Training and Conferences

The third year of fellowship training focuses primarily on elective time to allow fellows to concentrate on areas of personal interest while reinforcing both clinical and research expertise. At least six months of this year must involve clinical rotations, with the remaining time potentially dedicated to research activities.

Continuity Clinic

Throughout all three years of fellowship training, fellows attend a weekly half-day Continuity Clinic, under the supervision of attending faculty. This clinic experience rotates every six months to provide varied exposure.

Educational Conferences

A structured series of weekly conferences supplements the fellows' educational journey, including:

• Monday Noon Case Review Conference
• Interdisciplinary Science Interface Seminar
• Research Progress Presentations
• Various Tumor Boards

Fellows are expected to present cases, research findings, and participate actively in discussions within these forums.

Application Information

The application for the fellowship, commencing on July 1, 2025, requires candidates to submit a full application via the Electronic Residency Application Service (ERAS). Important application elements include:

• Curriculum Vitae
• USMLE Scores
• Letter of Recommendation from the Residency Program Director
• Two Additional Letters of Recommendation
• Photograph
• Medical School Transcript
• Medical School Performance Evaluation
• Personal Statement

Notably, this program supports J-1 visas only and does not sponsor H-1B visas.

Competitiveness and Diversity

As an esteemed program, it represents a highly competitive option for prospective candidates. The fellowship encourages a diverse array of applicants, including those from international medical backgrounds.